These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30209913)

  • 1. Update in Infectious Diseases 2018.
    Candel FJ; Emilov T; Diaz de la Torre I; Ruedas A; Viñuela Prieto JM; Visiedo C; Martínez-Jordán J; López-González L; Matesanz M; Arribi A
    Rev Esp Quimioter; 2018 Sep; 31 Suppl 1(Suppl 1):1-8. PubMed ID: 30209913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update in Infectious Diseases 2019.
    Candel FJ; Rico CM; Díaz de la Torre I; Laguna B; Martínez-Jordán J; Medrano S; Escobar-Porcel MC; López-Delgado A; López-González L; Viñuela-Prieto JM; Matesanz M; González Del Castillo J; Arribi A
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):1-9. PubMed ID: 31475801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant publications on infectious diseases pharmacotherapy in 2013.
    Hunter AS; Guervil DJ; Perez KK; Schilling AN; Verheyden CN; Vuong NN; Xu R;
    Am J Health Syst Pharm; 2014 Nov; 71(22):1974-88. PubMed ID: 25349243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update in Infectious Diseases 2017.
    Candel FJ; Peñuelas M; Lejárraga C; Emilov T; Rico C; Díaz I; Lázaro C; Viñuela-Prieto JM; Matesanz M
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():1-7. PubMed ID: 28882006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to XII Updating Course of Antimicrobials and Infectious Diseases.
    Candel FJ
    Rev Esp Quimioter; 2022 Oct; 35 Suppl 3(Suppl 3):1. PubMed ID: 36285847
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction to XI Updating Course of Antimicrobials and Infectious Diseases.
    Candel FJ
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):1. PubMed ID: 34598412
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction to XIII Updating Course of Antimicrobials and Infectious Diseases.
    Candel FJ
    Rev Esp Quimioter; 2023 Nov; 36 Suppl 1(Suppl 1):1. PubMed ID: 37997860
    [No Abstract]   [Full Text] [Related]  

  • 8. Significant publications on infectious diseases pharmacotherapy in 2008.
    Kuper KM; Hirsch EB; Tam VH;
    Am J Health Syst Pharm; 2009 Oct; 66(19):1726-34. PubMed ID: 19767379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant Publications on Infectious Diseases Pharmacotherapy in 2018.
    Borjan J; Gonzales-Luna AJ; Carlson TJ; Finch NA; Mitchell AP; McDaneld PM; Phe K; Foolad F
    J Pharm Pract; 2019 Oct; 32(5):546-557. PubMed ID: 31327285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Companion and complementary diagnostics for infectious diseases.
    Dailey PJ; Elbeik T; Holodniy M
    Expert Rev Mol Diagn; 2020 Jun; 20(6):619-636. PubMed ID: 32031431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant publications on infectious diseases pharmacotherapy in 2009.
    Palmer HR; Cottreau JM; Garey KW; Hirsch EB; Musick WL; Tam VH; Yeh RF;
    Am J Health Syst Pharm; 2010 Aug; 67(15):e34-42. PubMed ID: 20651305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The statement from 6 infectious diseases-related academic societies towards the further understanding of the necessity for the innovation/development of novel antimicrobials and the current status of antibiotic-resistant bacteria].
    Kansenshogaku Zasshi; 2014 Jul; 88(4):409-16. PubMed ID: 25199373
    [No Abstract]   [Full Text] [Related]  

  • 13. Significant publications on infectious diseases pharmacotherapy in 2011.
    Tran TT; Beyda ND; Biehle LR; Cottreau JM; Echevarria K; Musick WL; Perez KK; Schilling AN;
    Am J Health Syst Pharm; 2012 Oct; 69(19):1671-81. PubMed ID: 22997121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance: A multifaceted problem with multipronged solutions.
    Gil-Gil T; Laborda P; Sanz-García F; Hernando-Amado S; Blanco P; Martínez JL
    Microbiologyopen; 2019 Nov; 8(11):e945. PubMed ID: 31724836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infectious diseases-Part II: New agents, resistances, and treatment strategies].
    Salzberger B; Franzen C; Glück T
    Med Klin (Munich); 2004 May; 99(5):251-60. PubMed ID: 15146288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical infectious diseases pharmacists in the United States: a problem of both supply and demand.
    Gauthier TP; Worley M; Laboy V; Hernandez L; Unger NR; Sherman EM; Frederick C; Aragon L
    Clin Infect Dis; 2015 Mar; 60(5):826-7. PubMed ID: 25409474
    [No Abstract]   [Full Text] [Related]  

  • 17. Significant Publications on Infectious Diseases Pharmacotherapy in 2016.
    Fong G; Skoglund EW; Phe K; Guastadisegni J; Shea KM; McDaneld PM; Perez KK; Sofjan AK
    J Pharm Pract; 2018 Oct; 31(5):469-480. PubMed ID: 28847232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19?
    Mormeneo Bayo S; García-Lechuz Moya JM
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):8-11. PubMed ID: 34598414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The management for elderly patients with infectious diseases].
    Nakamura S; Miyazaki Y; Kono S
    Nihon Ronen Igakkai Zasshi; 2005 Mar; 42(2):129-36. PubMed ID: 15852637
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Wolfe CR; Ison MG;
    Clin Transplant; 2019 Sep; 33(9):e13547. PubMed ID: 30903670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.